Bullish On GEHC? You Might Want To Consider This Credit Put Spread Expiring in 23 Days
Market Chameleon (Wed, 9-Oct 9:06 AM ET)
Business Wire (Wed, 9-Oct 9:00 AM ET)
GE HealthCare to announce third quarter 2024 results on October 30, 2024
Business Wire (Tue, 8-Oct 8:00 AM ET)
GE HealthCare takes role in consortium for cancer care for patients in Europe
Seeking Alpha News (Mon, 7-Oct 9:24 AM ET)
Business Wire (Mon, 7-Oct 9:00 AM ET)
Buy Rating for GE Healthcare Technologies Inc. on Flyrcado’s Market Disruption Potential
TipRanks (Mon, 7-Oct 6:06 AM ET)
Business Wire (Mon, 7-Oct 2:30 AM ET)
Business Wire (Fri, 27-Sep 4:32 PM ET)
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
Business Wire (Thu, 26-Sep 9:00 AM ET)
Business Wire (Thu, 19-Sep 9:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of October 9, 2024, GEHC stock price climbed to $90.77 with 1,669,824 million shares trading.
GEHC has a beta of 0.93, meaning it tends to be less sensitive to market movements. GEHC has a correlation of 0.19 to the broad based SPY ETF.
GEHC has a market cap of $41.43 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $5 billion in Revenue and $1.00 earnings per share. This fell short of revenue expectation by $-31 million and exceeded earnings estimates by $.02.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, SPY.
GEHC has underperformed the market in the last year with a price return of +32.8% while the SPY ETF gained +36.0%. However, in the short term, GEHC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.9% vs +4.3% return in SPY. But in the last 2 weeks, GEHC shares have been beat by the market, returning -1.6% compared to an SPY return of +1.0%.
GEHC support price is $89.29 and resistance is $92.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.